
Patrick Wood
Stock Analyst at UBS
(1.46)
# 3,668
Out of 5,152 analysts
460
Total ratings
53.8%
Success rate
-0.1%
Average return
Main Sectors:
Stocks Rated by Patrick Wood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Reiterated: Buy | $8 → $14 | $10.77 | +25.35% | 11 | Nov 12, 2026 | |
| BDX Becton, Dickinson and Company | Rated: Buy | $205 → $242 | $216.08 | +12.00% | 18 | Nov 9, 2026 | |
| SOLV Solventum | Reiterated: Buy | $101 → $105 | $86.48 | +21.42% | 16 | Nov 9, 2026 | |
| TMDX TransMedics Group | Rated: Hold | $77 → $88 | $96.43 | -8.74% | 25 | Nov 9, 2026 | |
| INSP Inspire Medical Systems | Reiterated: Sell | $39 → $45 | $58.11 | -22.56% | 7 | Nov 6, 2026 | |
| STE STERIS | Reiterated: Buy | $270 → $290 | $259.57 | +11.72% | 13 | Nov 6, 2026 | |
| EW Edwards Lifesciences | Rated: Buy | $110 → $118 | $105.23 | +12.14% | 19 | Nov 5, 2026 | |
| PODD Insulet | Rated: Hold | $150 → $171 | $139.98 | +22.16% | 18 | Nov 5, 2026 | |
| PRCT PROCEPT BioRobotics | Rated: Hold | $20 → $21 | $25.18 | -16.60% | 11 | Nov 5, 2026 | |
| ZBH Zimmer Biomet Holdings | Rated: Buy | $120 → $130 | $103.32 | +25.82% | 12 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $16 → $8.5 | $7.06 | +20.40% | 8 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 → $26 | $23.54 | +10.45% | 8 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $172 → $241 | $233.08 | +3.40% | 11 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 → $364 | $318.15 | +14.41% | 8 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $96 → $107 | $82.52 | +29.67% | 17 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $67 → $57 | $43.64 | +30.61% | 22 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $19 → $14 | $13.86 | +1.01% | 5 | Oct 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $500 | $420.95 | +18.78% | 14 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $51 → $44 | $27.10 | +62.36% | 2 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $25 | $14.33 | +74.46% | 2 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $75 → $66 | $60.75 | +8.64% | 16 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $100 → $110 | $100.72 | +9.21% | 17 | Sep 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $28 | $16.99 | +64.80% | 2 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $145 → $158 | $165.85 | -4.73% | 16 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $27 → $28 | $20.65 | +35.59% | 8 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 | $17.05 | +5.57% | 15 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5.5 → $6.3 | $5.01 | +25.75% | 18 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 → $23 | $20.95 | +9.79% | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $137 → $125 | $104.48 | +19.64% | 13 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $15 → $25 | $26.16 | -4.43% | 15 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $100 → $82 | $70.53 | +16.26% | 5 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $13 → $20 | $25.35 | -21.10% | 11 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 66.82 | CHF 62.32 | +7.23% | 11 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $39.16 | +22.57% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $35 | $45.89 | -23.73% | 4 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $80 → $85 | $83.66 | +1.60% | 15 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $195 → $205 | $94.87 | +116.09% | 5 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $185 | $333.25 | n/a | 1 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $195 → $220 | $289.50 | n/a | 2 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $266 | $320.60 | n/a | 2 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $560 → $656 | $692.74 | n/a | 2 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 | $63.62 | n/a | 1 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 | $15.37 | n/a | 1 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $220 | $257.84 | n/a | 1 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $0.8532 | n/a | 3 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 | $0.0187 | n/a | 2 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $34 | $15.36 | n/a | 1 | Aug 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $30 → $16 | $29.81 | n/a | 2 | Oct 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 1,473p | 1,148p | n/a | 1 | Feb 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €35.31 → €45.00 | €27.16 | n/a | 2 | Jul 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €64.58 → €42.00 | €53.43 | n/a | 2 | Dec 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | CHF 267.00 | CHF 666.60 | n/a | 1 | Jan 31, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $20.95 | n/a | 1 | Jul 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $161.79 | n/a | 2 | Dec 11, 2017 |
Sight Sciences
Nov 12, 2026
Reiterated: Buy
Price Target: $8 → $14
Current: $10.77
Upside: +25.35%
Becton, Dickinson and Company
Nov 9, 2026
Rated: Buy
Price Target: $205 → $242
Current: $216.08
Upside: +12.00%
Solventum
Nov 9, 2026
Reiterated: Buy
Price Target: $101 → $105
Current: $86.48
Upside: +21.42%
TransMedics Group
Nov 9, 2026
Rated: Hold
Price Target: $77 → $88
Current: $96.43
Upside: -8.74%
Inspire Medical Systems
Nov 6, 2026
Reiterated: Sell
Price Target: $39 → $45
Current: $58.11
Upside: -22.56%
STERIS
Nov 6, 2026
Reiterated: Buy
Price Target: $270 → $290
Current: $259.57
Upside: +11.72%
Edwards Lifesciences
Nov 5, 2026
Rated: Buy
Price Target: $110 → $118
Current: $105.23
Upside: +12.14%
Insulet
Nov 5, 2026
Rated: Hold
Price Target: $150 → $171
Current: $139.98
Upside: +22.16%
PROCEPT BioRobotics
Nov 5, 2026
Rated: Hold
Price Target: $20 → $21
Current: $25.18
Upside: -16.60%
Zimmer Biomet Holdings
Nov 5, 2026
Rated: Buy
Price Target: $120 → $130
Current: $103.32
Upside: +25.82%
Nov 4, 2026
Downgraded: Hold
Price Target: $16 → $8.5
Current: $7.06
Upside: +20.40%
Nov 3, 2026
Rated: Buy
Price Target: $25 → $26
Current: $23.54
Upside: +10.45%
Nov 2, 2026
Reiterated: Hold
Price Target: $172 → $241
Current: $233.08
Upside: +3.40%
Nov 2, 2026
Reiterated: Buy
Price Target: $400 → $364
Current: $318.15
Upside: +14.41%
Oct 30, 2026
Rated: Buy
Price Target: $96 → $107
Current: $82.52
Upside: +29.67%
Oct 29, 2026
Rated: Buy
Price Target: $67 → $57
Current: $43.64
Upside: +30.61%
Oct 27, 2026
Rated: Hold
Price Target: $19 → $14
Current: $13.86
Upside: +1.01%
Oct 13, 2026
Reiterated: Buy
Price Target: $500
Current: $420.95
Upside: +18.78%
Oct 5, 2026
Reiterated: Buy
Price Target: $51 → $44
Current: $27.10
Upside: +62.36%
Sep 15, 2026
Reiterated: Buy
Price Target: $22 → $25
Current: $14.33
Upside: +74.46%
Sep 10, 2026
Rated: Hold
Price Target: $75 → $66
Current: $60.75
Upside: +8.64%
Sep 3, 2026
Rated: Buy
Price Target: $100 → $110
Current: $100.72
Upside: +9.21%
Sep 2, 2026
Reiterated: Buy
Price Target: $25 → $28
Current: $16.99
Upside: +64.80%
Aug 11, 2026
Reiterated: Hold
Price Target: $145 → $158
Current: $165.85
Upside: -4.73%
Aug 10, 2026
Rated: Buy
Price Target: $27 → $28
Current: $20.65
Upside: +35.59%
Aug 7, 2026
Reiterated: Hold
Price Target: $18
Current: $17.05
Upside: +5.57%
Aug 6, 2026
Reiterated: Hold
Price Target: $5.5 → $6.3
Current: $5.01
Upside: +25.75%
Jul 30, 2026
Initiated Coverage: Buy
Price Target: $21 → $23
Current: $20.95
Upside: +9.79%
Jul 28, 2026
Rated: Buy
Price Target: $137 → $125
Current: $104.48
Upside: +19.64%
Jul 28, 2026
Rated: Hold
Price Target: $15 → $25
Current: $26.16
Upside: -4.43%
Jul 28, 2026
Initiated Coverage: Hold
Price Target: $100 → $82
Current: $70.53
Upside: +16.26%
Jul 28, 2026
Initiated Coverage: Sell
Price Target: $13 → $20
Current: $25.35
Upside: -21.10%
Mar 11, 2026
Reiterated: Hold
Price Target: CHF 66.82
Current: CHF 62.32
Upside: +7.23%
Feb 25, 2026
Reiterated: Buy
Price Target: $48
Current: $39.16
Upside: +22.57%
Feb 17, 2026
Reiterated: Hold
Price Target: $35
Current: $45.89
Upside: -23.73%
Feb 5, 2026
Reiterated: Hold
Price Target: $80 → $85
Current: $83.66
Upside: +1.60%
Dec 2, 2025
Reiterated: Buy
Price Target: $195 → $205
Current: $94.87
Upside: +116.09%
Nov 11, 2025
Reiterated: Hold
Price Target: $185
Current: $333.25
Upside: n/a
Nov 11, 2025
Reiterated: Buy
Price Target: $195 → $220
Current: $289.50
Upside: n/a
Nov 6, 2025
Reiterated: Hold
Price Target: $266
Current: $320.60
Upside: n/a
Oct 28, 2025
Reiterated: Buy
Price Target: $560 → $656
Current: $692.74
Upside: n/a
Aug 12, 2025
Reiterated: Buy
Price Target: $68
Current: $63.62
Upside: n/a
Aug 4, 2025
Reiterated: Hold
Price Target: $12
Current: $15.37
Upside: n/a
Jul 23, 2025
Reiterated: Buy
Price Target: $220
Current: $257.84
Upside: n/a
May 27, 2025
Reiterated: Hold
Price Target: $6
Current: $0.8532
Upside: n/a
Jun 13, 2024
Reiterated: Hold
Price Target: $18
Current: $0.0187
Upside: n/a
Aug 24, 2023
Downgraded: Hold
Price Target: $34
Current: $15.36
Upside: n/a
Oct 4, 2022
Reiterated: Hold
Price Target: $30 → $16
Current: $29.81
Upside: n/a
Feb 22, 2022
Reiterated: Buy
Price Target: 1,473p
Current: 1,148p
Upside: n/a
Jul 28, 2021
Downgraded: Hold
Price Target: €35.31 → €45.00
Current: €27.16
Upside: n/a
Dec 3, 2020
Downgraded: Hold
Price Target: €64.58 → €42.00
Current: €53.43
Upside: n/a
Jan 31, 2019
Downgraded: Hold
Price Target: CHF 267.00
Current: CHF 666.60
Upside: n/a
Jul 9, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $20.95
Upside: n/a
Dec 11, 2017
Upgraded: Buy
Price Target: n/a
Current: $161.79
Upside: n/a